Intracranial metastasis in fibrolamellar hepatocellular carcinoma
- PMID: 29286561
- PMCID: PMC6028006
- DOI: 10.1002/pbc.26919
Intracranial metastasis in fibrolamellar hepatocellular carcinoma
Abstract
Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare liver malignancy in adolescents and young adults. Surgery is the mainstay of therapy for primary and metastatic disease. Most patients relapse, with development of both local and distant metastases. Brain metastases from solid tumors are rare in the pediatric and young adult population. Here, we document three patients with brain metastases from FLHCC, confirmed by histology and molecular characterization of the chimeric fusion DNAJB1-PRKACA, each necessitating neurosurgical intervention. These observations highlight the ability of FLHCC to metastasize to the brain and suggest the need for surveillance neuroimaging for patients with advanced-stage disease.
Keywords: adolescent and young adult tumors; brain; fibrolamellar; liver; rare tumors; tumor biology; tumors.
© 2017 Wiley Periodicals, Inc.
Conflict of interest statement
The authors of the manuscript have no conflicts of interest to disclose.
Figures
References
-
- El-Serag HB, Davila JA. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology. 2004;39:798–803. - PubMed
-
- Mavros MN, Mayo SC, Hyder O, et al. A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma. J Am Coll Surg. 2012;215:820–30. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
